Gemcitabine Plus Erlotinib Versus Erlotinib Plus Gemcitabine Plus Oxaliplatin, in Pancreatic Cancer
Clinical trial NCT00564720 · TERMINATED
Trial details
- NCT number
- NCT00564720
- Sponsor
- Hellenic Oncology Research Group
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2011-03-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.